2024
Fluorescence-detection size-exclusion chromatography specifically detects autoantibodies targeting the ganglionic acetylcholine receptor in patients with autoimmune autonomic ganglionopathy
Baxter L, Hopkins S, O'Connor K, Pham M, Nowak R, Monson N, Blackburn K, Hibbs R, Vernino S, Noviello C. Fluorescence-detection size-exclusion chromatography specifically detects autoantibodies targeting the ganglionic acetylcholine receptor in patients with autoimmune autonomic ganglionopathy. Journal Of Neuroimmunology 2024, 396: 578454. PMID: 39277987, DOI: 10.1016/j.jneuroim.2024.578454.Peer-Reviewed Original ResearchAutoimmune autonomic ganglionopathyGanglionic acetylcholine receptorAutonomic ganglionopathyRadioimmunoprecipitation assayFluorescence-detection size-exclusion chromatographyAcetylcholine receptorsAutoantibody detectionClinical symptomsDetect autoantibodiesAutoimmune diseasesHealthy controlsPatient seraSize-exclusion-chromatographyAutoantibodiesGAChRGanglionopathySize exclusion chromatographyPatientsReceptors
2022
Longitudinally extensive dorsal column spinal cord lesion with sensory ganglionopathy
Cardenas Castillo YM, Zubair AS, DiCapua D, Aguila-Tejedor I, Usman U. Longitudinally extensive dorsal column spinal cord lesion with sensory ganglionopathy. Neurological Sciences 2022, 43: 5157-5159. PMID: 35482156, DOI: 10.1007/s10072-022-06003-0.Peer-Reviewed Case Reports and Technical NotesConceptsMagnetic resonance imagingSensory ganglionopathyTotal spine magnetic resonance imagingRepeat magnetic resonance imagingSpine magnetic resonance imagingHigh-dose steroidsProgressive gait unsteadinessSpinal cord lesionsInfectious workupGait unsteadinessPosterior cordCord lesionsElectrodiagnostic testingMotor strengthNeurologic examinationWallerian degenerationCeliac diseaseSensory ataxiaCord signalHyperintense signalSensory axonsPartial improvementResonance imagingVitamin B12Ganglionopathy
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply